vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and SYNCHRONOSS TECHNOLOGIES INC (SNCR). Click either name above to swap in a different company.

SYNCHRONOSS TECHNOLOGIES INC is the larger business by last-quarter revenue ($42.0M vs $37.2M, roughly 1.1× Organogenesis Holdings Inc.). On growth, SYNCHRONOSS TECHNOLOGIES INC posted the faster year-over-year revenue change (-2.2% vs -57.1%). Over the past eight quarters, SYNCHRONOSS TECHNOLOGIES INC's revenue compounded faster (0.7% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

ORGO vs SNCR — Head-to-Head

Bigger by revenue
SNCR
SNCR
1.1× larger
SNCR
$42.0M
$37.2M
ORGO
Growing faster (revenue YoY)
SNCR
SNCR
+54.8% gap
SNCR
-2.2%
-57.1%
ORGO
Faster 2-yr revenue CAGR
SNCR
SNCR
Annualised
SNCR
0.7%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ORGO
ORGO
SNCR
SNCR
Revenue
$37.2M
$42.0M
Net Profit
$5.8M
Gross Margin
30.8%
79.4%
Operating Margin
-185.1%
14.0%
Net Margin
13.8%
Revenue YoY
-57.1%
-2.2%
Net Profit YoY
201.7%
EPS (diluted)
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
SNCR
SNCR
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$150.9M
$42.0M
Q2 25
$101.0M
$42.5M
Q1 25
$86.7M
$42.2M
Q4 24
$126.7M
$44.2M
Q3 24
$115.2M
$43.0M
Q2 24
$130.2M
$43.5M
Net Profit
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
$5.8M
Q2 25
$-9.4M
$-19.6M
Q1 25
$-18.8M
$-3.8M
Q4 24
$7.7M
$7.9M
Q3 24
$12.3M
$-5.7M
Q2 24
$-17.0M
$-494.0K
Gross Margin
ORGO
ORGO
SNCR
SNCR
Q1 26
30.8%
Q4 25
Q3 25
79.4%
Q2 25
79.0%
Q1 25
72.6%
79.4%
Q4 24
75.5%
78.6%
Q3 24
76.7%
79.1%
Q2 24
77.6%
76.1%
Operating Margin
ORGO
ORGO
SNCR
SNCR
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
13.7%
14.0%
Q2 25
-12.5%
16.1%
Q1 25
-30.9%
19.5%
Q4 24
8.1%
16.5%
Q3 24
5.4%
12.8%
Q2 24
-10.7%
9.9%
Net Margin
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
19.4%
Q3 25
14.3%
13.8%
Q2 25
-9.3%
-46.1%
Q1 25
-21.7%
-9.0%
Q4 24
6.1%
17.8%
Q3 24
10.7%
-13.3%
Q2 24
-13.1%
-1.1%
EPS (diluted)
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
$0.31
Q3 25
$0.11
$0.51
Q2 25
$-0.10
$-1.87
Q1 25
$-0.17
$-0.37
Q4 24
$0.05
$0.75
Q3 24
$0.09
$-0.56
Q2 24
$-0.13
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
SNCR
SNCR
Cash + ST InvestmentsLiquidity on hand
$91.4M
$34.8M
Total DebtLower is stronger
$163.2M
Stockholders' EquityBook value
$55.4M
Total Assets
$520.0M
$278.2M
Debt / EquityLower = less leverage
2.95×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
SNCR
SNCR
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
$34.8M
Q2 25
$73.1M
$24.6M
Q1 25
$110.0M
$29.1M
Q4 24
$135.6M
$33.4M
Q3 24
$94.3M
$25.2M
Q2 24
$89.9M
$23.6M
Total Debt
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
Q3 25
$163.2M
Q2 25
$186.2M
Q1 25
$187.0M
Q4 24
$186.7M
Q3 24
$62.3M
$186.4M
Q2 24
$63.8M
$186.2M
Stockholders' Equity
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
$300.1M
Q3 25
$255.1M
$55.4M
Q2 25
$233.2M
$49.4M
Q1 25
$242.9M
$35.4M
Q4 24
$262.9M
$29.8M
Q3 24
$278.5M
$35.3M
Q2 24
$263.5M
$30.6M
Total Assets
ORGO
ORGO
SNCR
SNCR
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$509.8M
$278.2M
Q2 25
$461.1M
$291.4M
Q1 25
$467.4M
$293.3M
Q4 24
$497.9M
$293.8M
Q3 24
$446.3M
$299.7M
Q2 24
$443.2M
$295.7M
Debt / Equity
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
Q3 25
2.95×
Q2 25
3.77×
Q1 25
5.28×
Q4 24
6.27×
Q3 24
0.22×
5.28×
Q2 24
0.24×
6.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
SNCR
SNCR
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$39.0M
FCF MarginFCF / Revenue
92.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
6.77×
TTM Free Cash FlowTrailing 4 quarters
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
$39.4M
Q3 25
$3.1M
$39.4M
Q2 25
$-32.9M
$2.3M
Q1 25
$-19.9M
$293.0K
Q4 24
$10.9M
$13.1M
Q3 24
$8.7M
$3.4M
Q2 24
$4.7M
$11.3M
Free Cash Flow
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
$39.0M
Q2 25
$-36.5M
$2.0M
Q1 25
$-23.6M
$-31.0K
Q4 24
$7.6M
$12.2M
Q3 24
$6.1M
$3.2M
Q2 24
$2.9M
$10.9M
FCF Margin
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
15.4%
Q3 25
0.6%
92.9%
Q2 25
-36.1%
4.6%
Q1 25
-27.2%
-0.1%
Q4 24
6.0%
27.6%
Q3 24
5.3%
7.5%
Q2 24
2.2%
25.2%
Capex Intensity
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
2.1%
Q3 25
1.5%
0.9%
Q2 25
3.6%
0.8%
Q1 25
4.2%
0.8%
Q4 24
2.7%
1.9%
Q3 24
2.2%
0.3%
Q2 24
1.4%
0.9%
Cash Conversion
ORGO
ORGO
SNCR
SNCR
Q1 26
Q4 25
0.90×
Q3 25
0.14×
6.77×
Q2 25
Q1 25
Q4 24
1.43×
1.66×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORGO
ORGO

Segment breakdown not available.

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

Related Comparisons